Back to News
Market Impact: 0.55

Marsh & McLennan stock rating upgraded by JPMorgan on valuation opportunity

JPMMMCAONRJFJEF
Company FundamentalsAnalyst EstimatesAnalyst InsightsCapital Returns (Dividends / Buybacks)Product LaunchesArtificial IntelligenceTechnology & InnovationInvestor Sentiment & Positioning
Marsh & McLennan stock rating upgraded by JPMorgan on valuation opportunity

JPMorgan upgraded Marsh & McLennan (MMC) to Overweight from Neutral, citing an attractive entry point due to valuation multiple compression that has brought its multiple in line with peers, despite slightly lowering its price target to $242. While acknowledging concerns such as moderated organic growth and personnel losses, JPMorgan views MMC as a strong franchise with modest expectations at an attractive valuation. This upgrade aligns with other positive analyst sentiments from Raymond James and Jefferies, as MMC simultaneously advances strategic initiatives like new AI-powered platforms and insurance facilities.

Analysis

Bitcoin price today: muted near $122k after record highs; US shutdown drags on Investing.com - JPMorgan upgraded Marsh & McLennan (NYSE:MMC) from Neutral to Overweight on Thursday, while slightly lowering its price target to $242.00 from $248.00. The upgrade comes as MMC’s valuation multiple has compressed from a 2-turn premium to AON at the beginning of the year to roughly in line based on forward adjusted EPS, creating what JPMorgan considers an attractive entry point. The company trades at a P/E ratio of 24.56 and maintains an impressive track record of 55 consecutive years of dividend payments, with a current yield of 1.76%.According to InvestingPro, there are 8 additional key insights available about MMC’s valuation and growth prospects. JPMorgan noted that organic growth at most brokers has moderated in recent quarters, with MMC’s top line slowing more significantly than peers’, contributing to tempered expectations and negative investor sentiment toward the stock. The firm identified several specific concerns weighing on MMC shares, including personnel losses and the company’s exposure to management consulting through its Oliver Wyman unit. Despite these challenges, JPMorgan views the current situation as "an opportunity to buy a strong franchise, with modest expectations at an attractive (although not overly depressed) valuation." In other recent news, Marsh McLennan announced a quarterly dividend of $0.90 per share, payable on November 14, 2025, to stockholders of record as of October 2, 2025. The company also introduced two AI-powered platforms through its Mercer unit, aimed at enhancing workforce analytics by providing comprehensive talent landscape analysis. Additionally, Marsh McLennan’s insurance broker, Marsh, launched BrokerSafe, a new insurance facility offering US freight brokers stable and affordable auto liability coverage. In terms of analyst updates, Raymond James reiterated its Outperform rating on Marsh McLennan, maintaining a positive outlook despite industry challenges. Meanwhile, Jefferies raised its price target for the company to $229, noting that Marsh McLennan delivered an in-line quarter. These developments highlight the company’s ongoing efforts to innovate and provide value to its stakeholders amid macroeconomic uncertainties. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C. Should you invest $1,000 in MMC right now? Ask WarrenAI, our powerful AI financial research assistant. It's just like ChatGPT for investors, but with access to 10 years of company data, a built-in screener, Wall Street analysts' reports, and earnings call transcripts for real-time, vetted insights. Get answers about MMC and thousands of other assets within seconds. JPMorgan upgraded Marsh & McLennan (MMC) to Overweight from Neutral, citing an attractive entry point due to valuation multiple compression, which has brought its forward adjusted EPS multiple in line with competitor AON. Despite a slight reduction in its price target to $242.00 from $248.00, the firm highlights MMC's P/E ratio of 24.56 and an impressive 55-year track record of dividend payments, currently yielding 1.76%. This suggests a compelling value proposition after recent market adjustments. Concerns identified include moderated organic growth compared to peers and personnel losses, alongside exposure from its Oliver Wyman unit, which have contributed to negative investor sentiment. However, JPMorgan views these challenges as creating an opportunity to invest in a strong franchise with modest expectations at an appealing valuation. Recent strategic initiatives include the launch of two AI-powered platforms through its Mercer unit for workforce analytics and the BrokerSafe insurance facility by Marsh, aiming to enhance product offerings and stable auto liability coverage. These developments, coupled with Raymond James reiterating an Outperform rating and Jefferies raising its price target to $229, indicate solid underlying business activity and positive analyst sentiment despite broader industry headwinds.